Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,200 | 121 | 99.7% |
| Education | $5.90 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $524.17 | 48 | $0 (2024) |
| GlaxoSmithKline, LLC. | $330.24 | 11 | $0 (2024) |
| ABBVIE INC. | $283.18 | 12 | $0 (2024) |
| Novo Nordisk Inc | $203.83 | 10 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $126.44 | 4 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $75.34 | 2 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $69.23 | 2 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $61.00 | 4 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $60.44 | 4 | $0 (2021) |
| Allergan Inc. | $50.46 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $440.62 | 20 | Novo Nordisk Inc ($108.62) |
| 2023 | $264.04 | 12 | AbbVie Inc. ($191.30) |
| 2022 | $193.96 | 10 | Novo Nordisk Inc ($39.94) |
| 2021 | $321.65 | 14 | Biohaven Pharmaceuticals, Inc. ($126.44) |
| 2020 | $85.68 | 5 | PFIZER INC. ($67.01) |
| 2019 | $436.05 | 42 | PFIZER INC. ($281.93) |
| 2018 | $340.77 | 11 | GlaxoSmithKline, LLC. ($144.44) |
| 2017 | $122.66 | 8 | PFIZER INC. ($61.13) |
All Payment Transactions
122 individual payment records from CMS Open Payments — Page 2 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/24/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2023 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Diagnostics | ||||||
| 03/09/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Obesity | ||||||
| 02/01/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: NEUROSCIENCE | ||||||
| 08/31/2022 | Hologic, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: Diagnostics | ||||||
| 08/08/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2022 | Acerus Pharmaceuticals Corporation | Natesto (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Urology Endocrinology Men's Health | ||||||
| 08/03/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: RESPIRATORY | ||||||
| 05/24/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Diabetes | ||||||
| 05/05/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/04/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Diabetes | ||||||
| 04/06/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/03/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: PRIMARY CARE | ||||||
| 02/22/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: VACCINES | ||||||
| 11/18/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2021 | Hologic, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Diagnostics | ||||||
| 10/18/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/16/2021 | Teva Pharmaceuticals USA, Inc. | AirDuo Digihaler (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Respiratory | ||||||
| 09/01/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Diabetes | ||||||
| 06/23/2021 | PFIZER INC. | PREMARIN (Drug), COLOGUARD DNA CAPTURE REAGENTS, REYVOW | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: WOMENS HEALTH | ||||||
| 06/17/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $3.66 | General |
| Category: PRIMARY CARE | ||||||
| 06/16/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $105.21 | General |
| Category: PRIMARY CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 908 | 1,742 | $461,746 | $134,703 |
| 2022 | 21 | 1,015 | 2,017 | $501,546 | $139,498 |
| 2021 | 19 | 1,017 | 1,867 | $477,181 | $132,912 |
| 2020 | 19 | 967 | 1,632 | $386,726 | $103,146 |
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 78 | 79 | $6,478 | $2,404 | 37.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 17 | $7,616 | $2,336 | 30.7% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 11 | 11 | $2,750 | $1,449 | 52.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 16 | 16 | $4,320 | $1,360 | 31.5% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Office | 2022 | 15 | 15 | $3,825 | $1,266 | 33.1% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Office | 2022 | 19 | 21 | $4,116 | $1,236 | 30.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 101 | 103 | $7,313 | $1,018 | 13.9% |
| 99318 | Nursing facility annual assessment, typically 30 minutes | Office | 2022 | 14 | 14 | $3,976 | $1,000 | 25.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 41 | 101 | $2,929 | $968.16 | 33.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 47 | 47 | $2,679 | $900.54 | 33.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 17 | 17 | $1,394 | $527.71 | 37.9% |
| 85610 | Blood test, clotting time | Office | 2022 | 11 | 75 | $2,250 | $317.61 | 14.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 157 | 387 | $129,414 | $33,618 | 26.0% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 84 | 464 | $127,136 | $32,557 | 25.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 145 | 145 | $56,985 | $19,937 | 35.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 58 | 122 | $27,460 | $8,465 | 30.8% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Office | 2021 | 55 | 62 | $24,056 | $6,262 | 26.0% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 32 | 107 | $22,149 | $5,715 | 25.8% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 82 | 82 | $15,006 | $5,381 | 35.9% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Office | 2021 | 30 | 31 | $15,345 | $4,249 | 27.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 17 | 21 | $9,408 | $2,898 | 30.8% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Office | 2021 | 16 | 23 | $9,269 | $2,590 | 27.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 12 | 12 | $5,364 | $2,107 | 39.3% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Office | 2021 | 24 | 24 | $6,120 | $2,036 | 33.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 91 | 91 | $7,462 | $1,607 | 21.5% |
About Dr. Brett Stecker, DO
Dr. Brett Stecker, DO is a Family Medicine healthcare provider based in Raynham, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114097599.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brett Stecker, DO has received a total of $2,205 in payments from pharmaceutical and medical device companies, with $440.62 received in 2024. These payments were reported across 122 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($2,200).
As a Medicare-enrolled provider, Stecker has provided services to 3,907 Medicare beneficiaries, totaling 7,258 services with total Medicare billing of $510,259. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Raynham, MA
- Active Since 11/09/2006
- Last Updated 03/06/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1114097599
Products in Payments
- CHANTIX (Drug) $266.98
- BEXSERO (Biological) $156.40
- NURTEC ODT (Drug) $140.30
- UBRELVY (Drug) $133.01
- VRAYLAR (Drug) $103.84
- PREVNAR 20 (Biological) $79.99
- PREVNAR - 13 (Biological) $77.64
- Wegovy (Drug) $70.63
- XARELTO (Drug) $69.23
- APTIMA (Device) $64.29
- Ozempic (Drug) $62.39
- APTIOM (Drug) $61.31
- LYRICA (Drug) $51.41
- VIBERZI (Drug) $50.46
- Veozah (Drug) $49.57
- AREXVY (Drug) $49.42
- TRELEGY ELLIPTA (Drug) $46.68
- LEQVIO (Drug) $45.46
- Rybelsus (Drug) $40.58
- QULIPTA (Drug) $31.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Raynham
Sejal Thakor, Md, MD
Family Medicine — Payments: $1,689
Ruth Barnert, Md, MD
Family Medicine — Payments: $728.25
Dr. Marcin Sprycha, Md, MD
Family Medicine — Payments: $467.86
Bruce Kaplan, Md, MD
Family Medicine — Payments: $350.79
Dr. Divjot Sooch, M.d, M.D
Family Medicine — Payments: $22.61
Cheng-Chieh Chuang, Md, MD
Family Medicine